Most Read News

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and 7.5 mg dosages.

The cosmetics company reported a profit of ₹5.85 Crore in the same quarter previous year. On a quarterly basis, net profit increased 4.1%.

The record SIP flows of ₹25,323 Crore in October 2024 highlights a new peak in the SIP journey

The 35.6% yoy growth in mutual fund folios in October 2024 shows that mutual funds are a truly retail franchise

The company observed reduced staff expenses and regulatory contributions, as well as a significant 14% quarter-on-quarter (QoQ) decrease.

The project is expected to take three years to complete, and the corporation will earn a 10-year maintenance contract for it.

EBITDA increased by 3% to ₹47.8 Crore in the second quarter of this fiscal year, up from ₹46.4 Crore in the same period last year.

On the last day of bidding, which was dominated by retail buyers, Sagility India's IPO was subscribed for 3.2 times.

Mutual fund AUM at ͅ₹67.26 Trillion was flat despite the sharp inflows in October as the market sell-off offset the inflows

Notably, more than 25% of these orders came from the EV segment, demonstrating the company's commitment to EV market growth.